A cell small in number but powerful in its ability to switch the immune system on or off is a unique hybrid of two well-known immune cell types, researchers report. The discovery of this rare hybrid could have implications for the efficacy of new therapies that manipulate these two cell types to treat diseases such as cancer and rheumatoid arthritis.